West Virginia University
Video from WBOY on Protea’s new partnership

WBOY Channel 12 featured WVUBI graduate tenant Protea Biosciences on the nightly news.

Protea Biosciences and Mayoly-Spindler Announce Human Clinical Trial for New Biopharmaceutical

Protea Biosciences, Inc. announced today that the company, in partnership with Mayoly-Spindler, a European pharmaceutical company, has commenced a Phase I/IIA human clinical trial for a new recombinant Lipase.

Protea Biosciences Continues to Make New Developments

Protea Biosciences continues to revolutionize the science of protein analysis.

Protea Biosciences Recieves Patent

Protea Biosciences continues to research and develop breakthrough medical technologies.

Protea Biosciences Press Release

Press release about Protea Biosciences

Protea Biosciences Paves Way for Research in West Virginia

Protea Biosciences is furthering medical research and development, not only in West Virginia, but worldwide.

Protea Biosciences Announces Collaboration With Gelcompany, Inc.

Protea Biosciences Announces Collaboration With Gelcompany, Inc. for Development of New Gel-Based Protein Separation Products

Protea CEO Steve Turner to present at Boston Biotech Conference

His presentation is titled “Protea – building a new proteomics franchise.”

Kevin DiGregorio: We benefit by working together

The executive director of TechConnectWV talks about WV collaboration.

Protea announces exclusive license agreement with Johns Hopkins University

Protea / Johns Hopkins University collaboration will focus on the development of new protein tests for cardiovascular disease.